Philip Gregory
Director/Board Member presso American Society of Gene & Cell Therapy
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Philip D.
Gregory is currently the Director at the American Society of Gene & Cell Therapy.
Previously, he held the position of Chief Scientific Officer & Senior VP-Research at Sangamo Therapeutics, Inc. from 2014 to 2015.
He also served as the Senior Vice President-Operations at Flextronics Components Group.
From 2015 to 2021, Dr. Gregory was the Chief Scientific Officer at bluebird bio, Inc. Additionally, he held the position of Chief Scientific Officer at 2seventy Bio, Inc. Dr. Gregory completed his undergraduate studies at The University of Sheffield and obtained a doctorate degree from Keble College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
2SEVENTY BIO, INC.
0.60% | 08/01/2024 | 310 280 ( 0.60% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Philip Gregory
| Società | Posizione | Inizio |
|---|---|---|
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Director/Board Member | 02/05/2019 |
Precedenti posizioni note di Philip Gregory
| Società | Posizione | Fine |
|---|---|---|
| BLUEBIRD BIO, INC. | Chief Tech/Sci/R&D Officer | 04/11/2021 |
| SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 29/05/2015 |
Flextronics Components Group
 Flextronics Components Group SemiconductorsElectronic Technology International DisplayWorks, Inc. used to manufacture display components. It was a manufacturer and designer of liquid crystal displays, modules and assemblies. The company's Sales offices were located in United States, Europe, Hong Kong, Singapore and China. International DisplayWorks was headquartered in Roseville, CA. | Chief Operating Officer | 30/11/2006 |
| 2SEVENTY BIO, INC. | Chief Tech/Sci/R&D Officer | - |
Formazione di Philip Gregory
| The University of Sheffield | Undergraduate Degree |
| Keble College | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| BLUEBIRD BIO, INC. | Health Technology |
| 2SEVENTY BIO, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Flextronics Components Group
Flextronics Components Group SemiconductorsElectronic Technology International DisplayWorks, Inc. used to manufacture display components. It was a manufacturer and designer of liquid crystal displays, modules and assemblies. The company's Sales offices were located in United States, Europe, Hong Kong, Singapore and China. International DisplayWorks was headquartered in Roseville, CA. | Electronic Technology |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Commercial Services |
- Borsa valori
- Insiders
- Philip Gregory
